Beta Bionics, Inc.
NASDAQ: BBNX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Sean T. Saint
- Employees
- 352
- Headquarters
- Irvine, United States
- IPO year
- 2025
- Market cap
- $656.4M
- Website
- https://www.betabionics.com
Loading BBNX…
Loading profile data…Frequently asked questions about BBNX
What does Beta Bionics, Inc. (BBNX) do?
Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to inventing, developing, and bringing to market solutions that improve the health and quality of life for individuals with diabetes who depend on insulin. The company's flagship product, the iLet Bionic Pancreas, is an automated insulin delivery system currently avail...
Where does BBNX trade?
Beta Bionics, Inc. (BBNX) trades on the NASDAQ Global Market.
What sector is BBNX in?
Beta Bionics, Inc. (BBNX) operates in the Healthcare sector, specifically in the Medical - Equipment & Services industry.
Who is the CEO of Beta Bionics, Inc.?
Sean T. Saint is the chief executive officer of Beta Bionics, Inc. (BBNX).
Where is Beta Bionics, Inc. headquartered?
Beta Bionics, Inc. is headquartered in United States.
Does BBNX pay a dividend?
Beta Bionics, Inc. (BBNX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BBNX go public?
Beta Bionics, Inc. (BBNX) completed its initial public offering in 2025.